June 6, 2010

Systematic Review: Erythropoiesis-Stimulating Agents in Patients With Chronic Kidney Disease

.   .   

This meta-analysis confirms that targeting higher hemoglobin levels in CKD increases risks for stroke, hypertension, and vascular access thrombosis and probably increases risks for death, serious cardiovascular events, and end-stage renal disease.

Related Articles:


Comments are closed.